Minerva Neurosciences Announces Board and Audit Committee Changes
Company Announcements

Minerva Neurosciences Announces Board and Audit Committee Changes

Minerva Neurosciences (NERV) has provided an update.

Jeryl Hilleman will step down from her position on the Board and Chair of the Audit Committee at Minerva Neurosciences, effective August 6, 2024, to pursue other opportunities, with no disagreements prompting her departure. Jan van Heek will assume the role of Chair, and Dr. David Kupfer will join the Audit Committee following Hilleman’s resignation.

See more data about NERV stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskMinerva Neurosciences Reports Positive Earnings Amid FDA Challenges
TheFlyMinerva reports Q3 EPS $2.97 vs. ($1.03) last year
Austin AngeloIs NERV a Buy, Before Earnings?
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App